Organization type
- Contract research organization (CRO)
Early phases
- Biomarker identification
- Target identification – new biological hypothesis
- Target validation – Hypothesis verification
Screening
-
Assay development
- In vivo screening models
-
Chemical libraries
- Functional genomics libraries
- Natural product extracts: plants, microbial, animal (invertebrates, insects)
- Small molecules (including natural product, DNA encoded libraries and fragment libraries)
- Screening and high throughput screening using small molecules (including natural product, DNA encoded libraries and fragment libraries)
Optimization phases
- In vivo animal models (including assay/model development and testing)
-
Preclinical phase (including assay/model development and testing)(non-regulatory and regulatory)
- Safety
- Toxicology
Terapeutic areas
- Autoimmunity / Inflammation
- Cancer
- Cardiovascular
- Dermatology
- Infectious diseases
- Nervous Central System
- Ophthalmology / Optometry
- Rare diseases
Additional activities
- CROs providing no-regulatory and regulatory services for drug discovery